- Home
- HCWB vs COOT Comparison
HCWB vs COOT Comparison
Compare HCWB & COOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- COOT
- Stock Information
- Founded
- HCWB 2018
- COOT 2020
- Country
- HCWB United States
- COOT Australia
- Employees
- HCWB N/A
- COOT N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- COOT
- Sector
- HCWB Health Care
- COOT
- Exchange
- HCWB Nasdaq
- COOT NYSE
- Market Cap
- HCWB 26.6M
- COOT 23.0M
- IPO Year
- HCWB 2021
- COOT N/A
- Fundamental
- Price
- HCWB $0.37
- COOT $1.18
- Analyst Decision
- HCWB
- COOT
- Analyst Count
- HCWB 0
- COOT 0
- Target Price
- HCWB N/A
- COOT N/A
- AVG Volume (30 Days)
- HCWB 274.4K
- COOT 41.0K
- Earning Date
- HCWB 11-14-2024
- COOT 01-01-0001
- Dividend Yield
- HCWB N/A
- COOT N/A
- EPS Growth
- HCWB N/A
- COOT N/A
- EPS
- HCWB N/A
- COOT N/A
- Revenue
- HCWB $3,495,990.00
- COOT $22,502,817.00
- Revenue This Year
- HCWB $229.19
- COOT N/A
- Revenue Next Year
- HCWB N/A
- COOT N/A
- P/E Ratio
- HCWB N/A
- COOT N/A
- Revenue Growth
- HCWB 22.27
- COOT 16.10
- 52 Week Low
- HCWB $0.28
- COOT $0.61
- 52 Week High
- HCWB $2.52
- COOT $11.96
- Technical
- Relative Strength Index (RSI)
- HCWB 43.55
- COOT 52.66
- Support Level
- HCWB $0.33
- COOT $1.09
- Resistance Level
- HCWB $0.38
- COOT $1.69
- Average True Range (ATR)
- HCWB 0.05
- COOT 0.14
- MACD
- HCWB -0.00
- COOT -0.02
- Stochastic Oscillator
- HCWB 25.97
- COOT 19.05
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About COOT AUSTRALIAN OILSEEDS HOLDINGS LTD
Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently.